Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleoside Acylation . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106478751B details a pyridine-free route for capecitabine intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN1022688C discloses novel 5'-deoxy-5-fluorocytidine derivatives with reduced toxicity. Discover cost-effective manufacturing and supply chain solutions for high-purity API intermediates.